Dechairo Bryan 4
4 · GeneDx Holdings Corp. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
GeneDx (WGS) COO Dechairo Bryan Sells Shares
What Happened
Dechairo Bryan, Chief Operating Officer of GeneDx Holdings Corp. (WGS), sold a total of 5,961 shares in open-market transactions on February 4, 2026, generating aggregate proceeds of approximately $510,875. The sales were reported in eight blocks with weighted average prices ranging from $83.04 to $91.92 per share (individual sale totals: 779 shares @ $83.04 = $64,684; 1,425 @ $83.83 = $119,456; 1,034 @ $84.93 = $87,816; 623 @ $86.35 = $53,796; 1,572 @ $87.66 = $137,804; 328 @ $88.66 = $29,082; 100 @ $90.45 = $9,045; 100 @ $91.92 = $9,192). These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. This is a sale (not a purchase) and is typically considered routine when done under a prearranged 10b5-1 plan.
Key Details
- Transaction date: February 4, 2026; Form 4 filed February 6, 2026 (timely filing).
- Total shares sold: 5,961; Total proceeds: ~$510,875.
- Reported prices are weighted averages; the sales occurred across price ranges of roughly $82.33–$91.92 per share (see footnotes for per-block ranges).
- Trades were executed under a Rule 10b5-1 plan adopted 9/15/2025 (footnote F1).
- Shares owned after the transactions: the reporting person beneficially owns RSUs representing contingent rights to receive up to 28,123 shares of Class A common stock (footnote F9).
- Transaction code: S = Sale.
Context
A 10b5-1 trading plan allows insiders to sell shares under a pre-set plan and is designed to reduce concerns that sales were based on non-public information; such sales are often routine and not necessarily a signal about company prospects. For retail investors, purchases by insiders may carry more weight as a bullish signal than routine, preplanned sales.
Insider Transaction Report
- Sale
Class A Common Stock
[F1][F2]2026-02-04$83.04/sh−779$64,684→ 5,182 total - Sale
Class A Common Stock
[F1][F3]2026-02-04$83.83/sh−1,425$119,456→ 3,757 total - Sale
Class A Common Stock
[F1][F4]2026-02-04$84.93/sh−1,034$87,816→ 2,723 total - Sale
Class A Common Stock
[F1][F5]2026-02-04$86.35/sh−623$53,796→ 2,100 total - Sale
Class A Common Stock
[F1][F6]2026-02-04$87.66/sh−1,572$137,804→ 528 total - Sale
Class A Common Stock
[F1][F7]2026-02-04$88.66/sh−328$29,082→ 200 total - Sale
Class A Common Stock
[F1][F8]2026-02-04$90.45/sh−100$9,045→ 100 total - Sale
Class A Common Stock
[F1][F9]2026-02-04$91.92/sh−100$9,192→ 0 total
Footnotes (9)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.33 to $83.31 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 8 of this Form 4.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.33 to $84.32 per share, inclusive.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.50 to $85.41 per share, inclusive.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.77 to $86.70 per share, inclusive.
- [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.30 to $88.26 per share, inclusive.
- [F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.34 to $88.80 per share, inclusive.
- [F8]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.44 to $90.51 per share, inclusive.
- [F9]Following the reported transactions, which were undertaken pursuant to the reporting person's 10b5-1 trading plan, the reporting person beneficially owned RSUs representing contingent rights to receive up to an aggregate 28,123 shares of Class A Common Stock, which RSUs vest according to their terms.